[Indications for antiviral therapy for chronic hepatitis B].
Okanoue
Takeshi
T
Saiseikai Suita Hospital.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000998:Antiviral Agents / Q000008:administration & dosage*; D015415:Biomarkers / Q000032:analysis; D002353:Carrier State; D003245:Consensus Statements as Topic; D004279:DNA, Viral / Q000032:analysis; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D007372:Interferons / Q000008:administration & dosage*; D007564:Japan; D019259:Lamivudine / Q000008:administration & dosage; D063065:Organophosphonates / Q000008:administration & dosage; D012955:Societies, Medical
D000998:Antiviral Agents; D015415:Biomarkers; D004279:DNA, Viral; D063065:Organophosphonates; D019259:Lamivudine; C413685:entecavir; D006147:Guanine; C053001:adefovir; D007372:Interferons; D000225:Adenine